trial · primary record
Placebo
Polycystic Ovary Syndrome
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 154 |
| Primary completion | 2025-12-10 |
| Primary endpoint | Total Testosterone |
| Registry ID | NCT03864068 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:42:58.890Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03864068
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Placebo · compound